All aboard the public financing train! Zentalis, Editas, Verastem, Praxis and Clene, among others, raise funds
Biotechs left and right announced stock sales this week after data drops at ASCO, the European Hematology Association’s annual meeting and elsewhere.
The famed genome …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.